In our research, it was also found that the expression level of KCC2 in several epithelial cancers (breast cancer, cervical cancer, colorectal cancer, kidney cancer, lung cancer, ovarian cancer, pancreatic cancer, and prostate cancer) was significant. This evidence concerns the gene SLC12A5 and breast carcinoma.